07.29 2019

AP Bio announces partnership and licensing agreement with Tasly Biopharma for bispecific antibody

AP Biosciences and Tasly Biopharmaceuticals Sign Cooperative Development and Licensing Agreement for New Bispecific Antibody Cancer Treatments